focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 338.00
Bid: 324.00
Ask: 343.00
Change: 0.00 (0.00%)
Spread: 19.00 (5.864%)
Open: 338.00
High: 0.00
Low: 0.00
Prev. Close: 338.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 Nov 2009 07:00

RNS Number : 8204B
Microgen PLC
03 November 2009
 



microgen

www.microgen.com

3 November 2009

INTERIM MANAGEMENT STATEMENT

Microgen plc ('Microgen' or 'Group'announces its Interim Management Statement covering the period from 1 July 2009 to the date of this announcement. Microgen announced its interim results for the period ending 30 June 2009 on 21 July 2009.

The Group's financial results for the three months ended 30 September 2009 are ahead of the Group's annual plan. The Group's balance sheet remains strong, with £17.5 million of cash (30 June 2009: £15.2 million) and net funds of £15.2 million (30 June 2009: £12.8 million) at 30 September 2009, including proceeds of approximately £0.8 million from the disposal of 54% of the Group's shareholding in Scisys plc.

In a separate announcement this morning, Microgen has announced the proposed disposal of the Billing Services Division ("BSD") to a subsidiary of Swiss Post for a cash consideration of £7.5 million before expenses. Subject to shareholder approval of the proposed disposal, a special dividend of 4.0 pence per share will be paid. As the core business of Microgen has evolved to be based around software and associated consultancy, BSD has become increasingly non-core with little strategic overlap with the other Microgen business activities. With the success of Microgen Aptitude, the Board considers that it is now the right time to dispose of the BSD operations. If approved by shareholders, the proposed disposal will produce an exceptional profit in the current financial year, which will be partially offset by a revaluation of the Group's freehold property in line with the decline in the commercial property market. Further details on the proposed disposal and the special dividend are provided in the separate announcement.

In the third quarter, Microgen Aptitude Solutions Division ("MASD"reported an operating profit, ahead of the Board's expectations. In the period, MASD won a major new banking customer in Asia for Microgen Accounting Hub and Microgen Aptitude. This project is now underway and additional opportunities for further Microgen Aptitude based products in this account are anticipated in the future. The two major USA prospects referred to in the trading update released on 7 July 2009 have now completed their design phase, although one of these prospects is likely to be delayed until the new year due to a change in FASB accounting rules. Even with this delay, the performance of the MASD business is ahead of the Group's annual plan and MASD now anticipates reporting an operating profit for the year as a whole. (For reference, MASD reported an operating loss of £0.6 million for the first half of 2009 and an operating loss of £2.4 million for 2008). Furthermore, with the currently contracted/scheduled business and the prospect opportunities, the Board anticipates a strong performance in 2010, which should materially compensate for the reduction in profit contribution associated with the disposal of BSD.

As reported at the interim results, the Financial Systems Division ("FSD") has experienced some effects of the economic climate, but the high levels of recurring revenue and strong profitability of the business provide resilience to the economic instability. This strong foundation is derived from the Group's emphasis on multi-year annual licensing. As a result, despite the market environment, the FSD strong operating margins and cash flow have been sustained. The Board has also reviewed the product portfolio within FSD and have decided to end-of-life a number of smaller product lines, with revenue in the first half of 2009 in the order of £0.3 million.

In summary, the Board is pleased that the Group is on track to exceed the Board's current expectations, which have, despite the economic environment, already been increased this year. The success in 2009 also provides an excellent platform for 2010 and the Group's strong balance sheet, further enhanced by the proposed disposal of BSD, provides the Board with the resources to consider acquisition opportunities if appropriate.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBJBMTMMBMMJL
Date   Source Headline
20th May 20244:38 pmRNSNotification of Major Holdings
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 202410:48 amRNSResult of AGM
14th May 20247:00 amRNSAGM Statement
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSNotification of Major Holdings
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:10 pmRNSTotal Voting Rights
30th Apr 20244:46 pmRNSGrant of awards under 2020 Deferred Bonus Plan
29th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSNotice of 2024 Annual General Meeting
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:46 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:01 amRNSAptitude to Accelerate Autonomous Finance
21st Mar 20247:01 amRNSShare buyback programme
21st Mar 20247:00 amRNSAudited Results for Year Ended 31 December 2023
21st Feb 20247:00 amRNSChange of Broker Arrangements
9th Feb 20247:00 amRNSHolding(s) in Company
31st Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
4th Jan 20247:00 amRNSFynapse Win
30th Nov 20237:00 amRNSAppointment of Chief Executive Officer
12th Oct 20237:00 amRNSHolding(s) in Company
2nd Oct 20232:17 pmRNSGrant of awards
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.